Kenvue Inc
KVUE23.010USD
+0.260+1.14%
Cierre 04/25, 16:00（ET）Cotizaciones retrasadas 15 min
44.04BCap. mercado
42.75P/E TTM
Más Datos de Kenvue Inc Compañía
Kenvue Inc. is a consumer health company. The Company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include Pain Care; Cough, Cold, and Allergy; and Other Self Care (Digestive Health; Smoking Cessation; Eye Care; and Other). The Skin Health and Beauty segment's product categories include face and body care and hair, sun, and others. The Essential Health segment's product categories include oral care, baby care and other essential health (women’s health, wound care, and other). Its differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, Band-Aid, Aveeno, Zyrtec, and Nicorette. The Company has a global footprint through which it sells and distributes its product portfolio in more than 165 countries across its four regions. The four region consists of North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).
Información de la empresa
Código de la empresaKVUE
Nombre de la empresaKenvue Inc
Fecha de salida a bolsaMay 04, 2023
Fundada en2022
Director ejecutivoMr. Thibaut Mongon
Número de empleados22000
Tipo de seguridadOrdinary Share
Fin del año fiscalMay 04
Dirección1 Kenvue Way
CiudadSUMMIT
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal07901
Teléfono19088741200
Sitio Webhttps://www.kenvue.com
Código de la empresaKVUE
Fecha de salida a bolsaMay 04, 2023
Fundada en2022
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Thibaut Mongon
Mr. Thibaut Mongon
Chief Executive Officer, Director
Chief Executive Officer, Director
216.47K
+8.04%
Ms. Meredith (Meri) Stevens
Ms. Meredith (Meri) Stevens
Chief Operations Officer
Chief Operations Officer
64.44K
+5.82%
Mr. Carlton Lawson
Mr. Carlton Lawson
Group President, Europe, Middle East and Africa and Latin America
Group President, Europe, Middle East and Africa and Latin America
56.32K
-14.66%
Mr. Paul Ruh
Mr. Paul Ruh
Chief Financial Officer
Chief Financial Officer
56.20K
+6.89%
Ms. Bing (Ellie) Xie
Ms. Bing (Ellie) Xie
Group President, Asia Pacific
Group President, Asia Pacific
47.60K
+8.84%
Dr. Caroline Tillett
Dr. Caroline Tillett
Chief Scientific Officer
Chief Scientific Officer
44.13K
+6.62%
Mr. Jan Meurer
Mr. Jan Meurer
Group President, North America
Group President, North America
33.18K
+15.35%
Ms. Luani Alvarado
Ms. Luani Alvarado
Chief People Officer
Chief People Officer
31.36K
+9.72%
Ms. Charmaine England
Ms. Charmaine England
Chief Growth Officer
Chief Growth Officer
29.06K
+5.68%
Mr. Michael E. Sneed
Mr. Michael E. Sneed
Independent Director
Independent Director
28.44K
+52.59%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Thibaut Mongon
Mr. Thibaut Mongon
Chief Executive Officer, Director
Chief Executive Officer, Director
216.47K
+8.04%
Ms. Meredith (Meri) Stevens
Ms. Meredith (Meri) Stevens
Chief Operations Officer
Chief Operations Officer
64.44K
+5.82%
Mr. Carlton Lawson
Mr. Carlton Lawson
Group President, Europe, Middle East and Africa and Latin America
Group President, Europe, Middle East and Africa and Latin America
56.32K
-14.66%
Mr. Paul Ruh
Mr. Paul Ruh
Chief Financial Officer
Chief Financial Officer
56.20K
+6.89%
Ms. Bing (Ellie) Xie
Ms. Bing (Ellie) Xie
Group President, Asia Pacific
Group President, Asia Pacific
47.60K
+8.84%
Dr. Caroline Tillett
Dr. Caroline Tillett
Chief Scientific Officer
Chief Scientific Officer
44.13K
+6.62%
Desglose de ingresos
Divisa: USDHora de actualización: dom., 6 de abr
Divisa: USDHora de actualización: dom., 6 de abr
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Face and Body Care
2.94B
19.00%
Other Self Care
2.32B
15.00%
Cough, Cold and Allergy
2.16B
14.00%
Pain Care
2.01B
13.00%
Other Essential Health
1.70B
11.00%
Other
4.33B
28.00%
Por regiónUSD
Nombre
Ganancia
Proporción
Northern America
7.58B
49.04%
Europe, Middle East, and Africa
3.56B
23.03%
Asia - Pacific
2.97B
19.24%
Latin America
1.34B
8.69%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Face and Body Care
2.94B
19.00%
Other Self Care
2.32B
15.00%
Cough, Cold and Allergy
2.16B
14.00%
Pain Care
2.01B
13.00%
Other Essential Health
1.70B
11.00%
Other
4.33B
28.00%
Accionista
Hora de actualización: vie., 21 de feb
Hora de actualización: vie., 21 de feb
Estadísticas de accionistas
Tipo
Estadísticas de accionistas
Accionista
Proporción
T. Rowe Price Associates, Inc.
12.62%
The Vanguard Group, Inc.
11.35%
State Street Global Advisors (US)
6.28%
Fidelity Management & Research Company LLC
5.53%
MFS Investment Management
4.89%
Other
59.34%
Estadísticas de accionistas
Accionista
Proporción
T. Rowe Price Associates, Inc.
12.62%
The Vanguard Group, Inc.
11.35%
State Street Global Advisors (US)
6.28%
Fidelity Management & Research Company LLC
5.53%
MFS Investment Management
4.89%
Other
59.34%
Tipo
Accionista
Proporción
Investment Advisor
47.13%
Investment Advisor/Hedge Fund
44.82%
Hedge Fund
3.00%
Research Firm
2.71%
Pension Fund
1.87%
Sovereign Wealth Fund
1.36%
Bank and Trust
1.18%
Family Office
0.19%
Family Office
0.19%
Participación institucional
Hora de actualización: dom., 19 de ene
Hora de actualización: dom., 19 de ene
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q1
1954
1.96B
102.81%
-254.82M
2024Q4
1944
1.96B
102.60%
-253.31M
2024Q3
1828
1.91B
99.61%
-331.64M
2024Q2
1723
1.90B
99.19%
-79.08M
2024Q1
1598
1.90B
99.47%
-51.94M
2023Q4
1442
1.89B
98.66%
-22.82M
2023Q3
1206
1.90B
99.22%
-343.08M
2023Q2
232
1.95B
101.85%
+1.90B
2023Q1
1
--
0.00%
-14.23K
2022Q4
1
--
0.00%
-14.23K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
T. Rowe Price Associates, Inc.
242.05M
12.66%
+8.03M
+3.43%
Dec 31, 2024
The Vanguard Group, Inc.
217.71M
11.39%
+1.67M
+0.77%
Dec 31, 2024
State Street Global Advisors (US)
120.40M
6.3%
-6.81M
-5.36%
Dec 31, 2024
Fidelity Management & Research Company LLC
106.19M
5.56%
-9.01M
-7.82%
Dec 31, 2024
MFS Investment Management
93.86M
4.91%
+10.11M
+12.07%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
93.06M
4.87%
+2.22M
+2.44%
Dec 31, 2024
Wellington Management Company, LLP
68.36M
3.58%
-10.72M
-13.56%
Dec 31, 2024
Geode Capital Management, L.L.C.
46.07M
2.41%
+1.39M
+3.12%
Dec 31, 2024
Harris Associates L.P.
31.52M
1.65%
+58.77K
+0.19%
Dec 31, 2024
Managed Account Advisors LLC
25.86M
1.35%
-11.13M
-30.10%
Dec 31, 2024
Ver más
ETFs relacionados
Hora de actualización: dom., 6 de abr
Hora de actualización: dom., 6 de abr
Nombre
Proporción
Renaissance IPO ETF
9.45%
VanEck Morningstar Wide Moat Value ETF
4.62%
Cullen Enhanced Equity Income ETF
3.98%
TBG Dividend Focus ETF
3.63%
TrueShares Low Volatility Equity Income ETF
3.14%
First Trust US Equity Opportunities ETF
3.04%
Invesco S&P 500 Equal Weight Consumer Staples ETF
2.94%
ProShares Ultra Consumer Staples
2.63%
Consumer Staples Select Sector SPDR Fund
2.62%
iShares US Consumer Staples ETF
2.26%
Ver más
Renaissance IPO ETF
Proporción9.45%
VanEck Morningstar Wide Moat Value ETF
Proporción4.62%
Cullen Enhanced Equity Income ETF
Proporción3.98%
TBG Dividend Focus ETF
Proporción3.63%
TrueShares Low Volatility Equity Income ETF
Proporción3.14%
First Trust US Equity Opportunities ETF
Proporción3.04%
Invesco S&P 500 Equal Weight Consumer Staples ETF
Proporción2.94%
ProShares Ultra Consumer Staples
Proporción2.63%
Consumer Staples Select Sector SPDR Fund
Proporción2.62%
iShares US Consumer Staples ETF
Proporción2.26%
Dividendos
Un total de
2.32B
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Jan 16, 2025
KVUE.NB Interim Cash Dividend of gross USD 0.205 paid on Feb 26, 2025 going ex on Feb 12, 2025
Feb 12, 2025
Feb 26, 2025
Feb 12, 2025
Oct 17, 2024
KVUE.NB Final Cash Dividend of gross USD 0.205 paid on Nov 27, 2024 going ex on Nov 13, 2024
Nov 13, 2024
Nov 27, 2024
Nov 13, 2024
Jul 25, 2024
KVUE.NB Interim Cash Dividend of gross USD 0.205 paid on Aug 28, 2024 going ex on Aug 14, 2024
Aug 14, 2024
Aug 28, 2024
Aug 14, 2024
Apr 25, 2024
KVUE.NB Interim Cash Dividend of gross USD 0.2 paid on May 22, 2024 going ex on May 07, 2024
May 08, 2024
May 22, 2024
May 07, 2024
Jan 25, 2024
KVUE.NB Interim Cash Dividend of gross USD 0.2 paid on Feb 28, 2024 going ex on Feb 13, 2024
Feb 14, 2024
Feb 28, 2024
Feb 13, 2024
Oct 26, 2023
KVUE.NB Final Cash Dividend of gross USD 0.2 paid on Nov 22, 2023 going ex on Nov 07, 2023
Nov 08, 2023
Nov 22, 2023
Nov 07, 2023
Jul 20, 2023
KVUE.NB Interim Cash Dividend of gross USD 0.2 paid on Sep 07, 2023 going ex on Aug 25, 2023
Aug 28, 2023
Sep 07, 2023
Aug 25, 2023
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos